Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390253 | SCV001591929 | pathogenic | not provided | 2022-06-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the C1QC protein in which other variant(s) (p.Gly76Arg) have been observed in individuals with C1QC-related conditions (PMID: 20635792). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 17070). This variant is also known as p.Arg41*. This premature translational stop signal has been observed in individuals with C1q deficiency (PMID: 8630118, 21654842). This variant is present in population databases (rs377549148, gnomAD 0.005%). This sequence change creates a premature translational stop signal (p.Arg69*) in the C1QC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 177 amino acid(s) of the C1QC protein. |
OMIM | RCV000018599 | SCV000038882 | pathogenic | C1Q deficiency | 1996-04-01 | no assertion criteria provided | literature only |